[go: up one dir, main page]

DE69906701D1 - Topische verwendung von loperamid zur behandlung mikrobieller infektionen - Google Patents

Topische verwendung von loperamid zur behandlung mikrobieller infektionen

Info

Publication number
DE69906701D1
DE69906701D1 DE69906701T DE69906701T DE69906701D1 DE 69906701 D1 DE69906701 D1 DE 69906701D1 DE 69906701 T DE69906701 T DE 69906701T DE 69906701 T DE69906701 T DE 69906701T DE 69906701 D1 DE69906701 D1 DE 69906701D1
Authority
DE
Germany
Prior art keywords
loperamide
microbial infections
topical use
treating microbial
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69906701T
Other languages
English (en)
Other versions
DE69906701T2 (de
Inventor
Carol Keene
Angus Malcolm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Application granted granted Critical
Publication of DE69906701D1 publication Critical patent/DE69906701D1/de
Publication of DE69906701T2 publication Critical patent/DE69906701T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/451Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69906701T 1998-02-05 1999-01-29 Topische verwendung von loperamid zur behandlung mikrobieller infektionen Expired - Lifetime DE69906701T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9802542 1998-02-05
GBGB9802542.2A GB9802542D0 (en) 1998-02-05 1998-02-05 New use
PCT/EP1999/000608 WO1999039711A1 (en) 1998-02-05 1999-01-29 Antimicrobial composition

Publications (2)

Publication Number Publication Date
DE69906701D1 true DE69906701D1 (de) 2003-05-15
DE69906701T2 DE69906701T2 (de) 2004-02-05

Family

ID=10826560

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69906701T Expired - Lifetime DE69906701T2 (de) 1998-02-05 1999-01-29 Topische verwendung von loperamid zur behandlung mikrobieller infektionen

Country Status (9)

Country Link
US (1) US6566374B1 (de)
EP (1) EP1052991B1 (de)
AT (1) ATE236633T1 (de)
DE (1) DE69906701T2 (de)
DK (1) DK1052991T3 (de)
ES (1) ES2196769T3 (de)
GB (1) GB9802542D0 (de)
PT (1) PT1052991E (de)
WO (1) WO1999039711A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9802542D0 (en) 1998-02-05 1998-04-01 Smithkline Beecham Plc New use
US7138459B2 (en) * 2004-04-02 2006-11-21 Adherent Laboratories, Inc. Water soluble contact lens blocking composition
US7220800B2 (en) * 2004-04-02 2007-05-22 Adherent Laboratories, Inc. Water soluble contact lens blocking composition with absorbent disintegrant
WO2007003941A1 (en) * 2005-07-06 2007-01-11 Cambridge Enterprise Limited Modulation of autophagy by calpain inhibition
US20080033021A1 (en) * 2006-08-02 2008-02-07 Susan Burke Wash composition for the handling of contact lenses
FR2969494B1 (fr) * 2010-12-22 2013-11-08 Expanscience Lab Extrait de parties aeriennes de gynandropsis gynandra ou cleome gynandra et compositions cosmetiques, dermatologiques le comprenant

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3906779A1 (de) 1989-03-03 1990-09-06 Hoechst Ag Mittel gegen tierparasiten
US5849761A (en) * 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
US6156771A (en) * 1997-08-28 2000-12-05 Rubin; Walter Method for alleviation of lower gastrointestinal disorders in a human patient
GB9802542D0 (en) 1998-02-05 1998-04-01 Smithkline Beecham Plc New use

Also Published As

Publication number Publication date
DK1052991T3 (da) 2003-08-04
ES2196769T3 (es) 2003-12-16
GB9802542D0 (en) 1998-04-01
EP1052991A1 (de) 2000-11-22
EP1052991B1 (de) 2003-04-09
WO1999039711A1 (en) 1999-08-12
DE69906701T2 (de) 2004-02-05
US6566374B1 (en) 2003-05-20
PT1052991E (pt) 2003-08-29
ATE236633T1 (de) 2003-04-15

Similar Documents

Publication Publication Date Title
DE60010456D1 (de) Pharmazeutische oder diätetische zusammensetzung zur prävention oder behandlung von hyperoxalurie
ATE325614T1 (de) Milchsäurebakterienkombination und deren verwendung zur behandlung und prävention von infektionen und entzündungen
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
DE59710183D1 (de) Topische mittel zur prophylaxe oder behandlung bakterieller hautinfektionen
DE60021266D1 (de) Verwendungen von zusammensetzungen zur behandlung oder vermeidung von schlafstörungen mit sehr niedrigdosierten cyclobenzaprine
DE60032795D1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
DE69711078D1 (de) Topische verwendung von kappa-opioidrezeptoragonisten zur behandlung von augenschmerz
DE59707519D1 (de) Verwendung von 1-hydroxy-2-pyridonen zur behandlung von hautinfektionen
DE60027429D1 (de) Dihydrobenzodiazepinen und deren verwendung zur behandlung von dyslipidämien
DE69925578D1 (de) Pharmazeutische zusammenstellung zur vorbeugung und behandlung von mit zellkrankheiten des augenhintergrundes zusammenhängenden krankheiten
ATE234617T1 (de) Verwendung des saredutant und seiner pharmazeutisch akzeptablen salze zur behandlung von schwere depression
DE69625883D1 (de) Zusammensetzung zur Reinigung und/oder Desinfektion von medizinischen Geräten
DE69906701D1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
ATE347888T1 (de) Verwendung von aivlosin zur behandlung und prevention der lawsonia-infektionen in schweinen.
DE69626816D1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
ATE251462T1 (de) Verfahren zur behandlung von narbengewebe
ATE278401T1 (de) Verwendung von riluzol zur behandlung von akustischen traumazuständen
EP1233967A4 (de) Pyridinone zur behandlung und vorbeugung bakterieller infektionen
DE69424679D1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
ATE200624T1 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
DE60109594D1 (de) R-eliprodil zur behandlung von glaucoma
DE69737088D1 (de) Therapeutisches agens zur behandlung von fiv infektionen
DE59911556D1 (de) Arzneimittel zur vermeidung oder behandlung von papillomavirus-spezifischem tumor
DE69906729D1 (de) Zusammensetzung und methode zur behandlung von pseudomonas aeruginosa infektionen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition